<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03752073</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00000397</org_study_id>
    <nct_id>NCT03752073</nct_id>
  </id_info>
  <brief_title>Comparison of Two Mechanical Methods of Outpatient Ripening of the Cervix</brief_title>
  <acronym>CORC</acronym>
  <official_title>Comparison of Two Mechanical Methods of Outpatient Ripening of the Cervix</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ochsner Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ochsner Health System</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized prospective trial of two mechanical methods of pre-induction cervical
      ripening agents.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Term, low risk patients requesting elective induction of labor who desire pre-induction
      cervical ripening at home will be randomized to receive an outpatient trans-cervical ripening
      balloon (17 F non-latex Foley catheter) or hygroscopic cervical dilator (Dilapan-S). Patients
      present to the hospital for their scheduled induction of labor approximately 12 hours later.

      We hypothesize that the trans-cervical balloon and hygroscopic dilators will show equivalent
      efficacy in cervical ripening, but that pain scores and patient satisfaction will be better
      with the hygroscopic dilators.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time from start of cervical ripening to delivery</measure>
    <time_frame>720-2160 minutes</time_frame>
    <description>Time in minutes from placement of cervical ripening agent to delivery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain of insertion</measure>
    <time_frame>First hour</time_frame>
    <description>Patient assessment of pain on insertion using pain analog scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain over duration of cervical ripening</measure>
    <time_frame>12-14 hours</time_frame>
    <description>Patient assessment of pain on admission using pain analog scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction with cervical ripening agent</measure>
    <time_frame>24-36 hours</time_frame>
    <description>Patient survey postpartum day #1 regarding cervical ripening experience</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Rate of device expulsion prior to admission</measure>
    <time_frame>12-14 hours</time_frame>
    <description>Number of patients reporting expulsion of the device prior to planned admission</description>
  </other_outcome>
  <other_outcome>
    <measure>Rate of onset of labor prior to planned admission</measure>
    <time_frame>12-14 hours</time_frame>
    <description>Number of patients presenting in active labor prior to planned admission divided by all enrolled patients</description>
  </other_outcome>
  <other_outcome>
    <measure>Rate of cesarean delivery</measure>
    <time_frame>12-36 hours</time_frame>
    <description>Number of patients requiring cesarean delivery divided by number of all enrolled patients</description>
  </other_outcome>
  <other_outcome>
    <measure>Rate of operative vaginal delivery</measure>
    <time_frame>12-36 hours</time_frame>
    <description>Number of patients requiring operative vaginal delivery divided by number of all enrolled patients</description>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of shoulder dystocia</measure>
    <time_frame>12-36 hours</time_frame>
    <description>Number of patients diagnosed with shoulder dystocia divided by number of all enrolled patients</description>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of intra-amniotic infection</measure>
    <time_frame>12-36 hours</time_frame>
    <description>Number of patients diagnosed with intra-amniotic infection (maternal temperature &gt;38C, maternal (&gt;120) or fetal (&gt;160) tachycardia) divided by number of all enrolled patients</description>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of post-partum hemorrhage</measure>
    <time_frame>12-36 hours</time_frame>
    <description>Number of patients diagnosed with post-partu hemorrhage (QBL &gt;1000 ml) divided by number of all enrolled patients</description>
  </other_outcome>
  <other_outcome>
    <measure>10 minute Apgar score &lt;7</measure>
    <time_frame>12-36 hours</time_frame>
    <description>Number of infants with 10 minute Apgar score &lt;7 divided by number of all enrolled patients</description>
  </other_outcome>
  <other_outcome>
    <measure>Base excess &gt;12</measure>
    <time_frame>12-36 hours</time_frame>
    <description>Number of infants with base excess &gt;12 divided by number of all enrolled patients</description>
  </other_outcome>
  <other_outcome>
    <measure>Umbilical cord gas pH &lt;7</measure>
    <time_frame>12-36 hours</time_frame>
    <description>Number of infants with umbilical cord gas &lt;7 divided by number of all enrolled patients</description>
  </other_outcome>
  <other_outcome>
    <measure>Composite score of adverse neonatal outcomes</measure>
    <time_frame>12-72 hours</time_frame>
    <description>Composite of perinatal adverse outcomes (the need for respiratory support within 72 hours after birth, Apgar score of 3 or less at 5 minutes, hypoxic-ischemic encephalopathy, seizure, infection (confirmed sepsis or pneumonia), aspiration syndrome, birth trauma (bone fracture, neurologic injury, or retinal hemorrhage), intracranial or subgaleal hemorrhage, or hypotension requiring vasopressor support)</description>
  </other_outcome>
  <other_outcome>
    <measure>Composite score of serious maternal morbidity or mortality</measure>
    <time_frame>12-72 hours</time_frame>
    <description>Composite score of serious maternal morbidity (e.g. uterine rupture, admission to intensive care unit, septicemia), or death.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Induction of Labor</condition>
  <arm_group>
    <arm_group_label>Trans-cervical cervical balloon</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>17 F non-latex Foley catheter will be placed and balloon filled with 30 cc of sterile normal saline.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hygroscopic cervical dilators</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dilapan-S hygroscopic dilators will be placed into the cervix at the level of the internal os.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Trans-cervical cervical balloon</intervention_name>
    <description>Insertion of Foley Catheter</description>
    <arm_group_label>Trans-cervical cervical balloon</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hygroscopic cervical dilator</intervention_name>
    <description>Insertion of Dilapan-s</description>
    <arm_group_label>Hygroscopic cervical dilators</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women between 39 and 41 weeks gestational age who desire elective induction of labor,
             based on reliable estimated gestational age (defined as ultrasonography performed
             before 14 weeks 0 days, or a certain last menstrual period consistent with
             ultrasonography performed before 21 weeks 0 days).

        Exclusion Criteria:

          -  1. Risk factors for placental insufficiency or intra-partum complication such as
             intra-uterine growth restriction, hypertensive disease, diabetes requiring insulin
             therapy, multiple gestation, history of previous hysterotomy, cholestasis of
             pregnancy, placental abnormalities including low lying placenta (&lt; 2 cm from cervical
             os), maternal cardiac disease, maternal pulmonary disease, known fetal anomaly, fetal
             demise, etc.

          -  2. Simplified Bishop score must be &lt;6 and cervical dilation &lt;2 cm.

          -  3. Women must be able to give informed consent.

          -  4. Concern regarding fetal well-being, conditions which preclude vaginal birth, group
             B strep carriers, patients who are HIV, Hep B or Hep C positive.

          -  5. Women allergic to povidone-iodine, aquacryl hydrogel or the latex-free Foley
             catheter.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brigid McCue, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ochsner Health Systems</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brigid McCue, MD</last_name>
    <phone>781-439-4936</phone>
    <email>brigid.mccue@ochsner.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Payton Olson, MD</last_name>
    <phone>318-525-4443</phone>
    <email>payton.olson@ochsner.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ochsner Baptist Hospital</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brigid McCue, MD</last_name>
      <phone>781-439-4936</phone>
      <email>brigid.mccue@ochsner.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Sciscione AC, Muench M, Pollock M, Jenkins TM, Tildon-Burton J, Colmorgen GH. Transcervical Foley catheter for preinduction cervical ripening in an outpatient versus inpatient setting. Obstet Gynecol. 2001 Nov;98(5 Pt 1):751-6.</citation>
    <PMID>11704164</PMID>
  </reference>
  <reference>
    <citation>Sciscione AC, Bedder CL, Hoffman MK, Ruhstaller K, Shlossman PA. The timing of adverse events with Foley catheter preinduction cervical ripening; implications for outpatient use. Am J Perinatol. 2014 Oct;31(9):781-6. doi: 10.1055/s-0033-1359718. Epub 2013 Dec 17.</citation>
    <PMID>24347259</PMID>
  </reference>
  <reference>
    <citation>Gilson GJ, Russell DJ, Izquierdo LA, Qualls CR, Curet LB. A prospective randomized evaluation of a hygroscopic cervical dilator, Dilapan, in the preinduction ripening of patients undergoing induction of labor. Am J Obstet Gynecol. 1996 Jul;175(1):145-9.</citation>
    <PMID>8694040</PMID>
  </reference>
  <reference>
    <citation>Shindo R, Aoki S, Yonemoto N, Yamamoto Y, Kasai J, Kasai M, Miyagi E. Hygroscopic dilators vs balloon catheter ripening of the cervix for induction of labor in nulliparous women at term: Retrospective study. PLoS One. 2017 Dec 22;12(12):e0189665. doi: 10.1371/journal.pone.0189665. eCollection 2017.</citation>
    <PMID>29272277</PMID>
  </reference>
  <results_reference>
    <citation>Kuper SG, Jauk VC, George DM, Edwards RK, Szychowski JM, Mazzoni SE, Wang MJ, Files P, Tita AT, Subramaniam A, Harper LM. Outpatient Foley Catheter for Induction of Labor in Parous Women: A Randomized Controlled Trial. Obstet Gynecol. 2018 Jul;132(1):94-101. doi: 10.1097/AOG.0000000000002678.</citation>
    <PMID>29889751</PMID>
  </results_reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>October 4, 2018</study_first_submitted>
  <study_first_submitted_qc>November 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 23, 2018</study_first_posted>
  <last_update_submitted>March 6, 2020</last_update_submitted>
  <last_update_submitted_qc>March 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

